Page 388 - Read Online

Page 18 of 18 Yelton et al. Neuroimmunol Neuroinflammation 2018;5:46 I http://dx.doi.org/10.20517/2347-8659.2018.58

85. Sampson JH, Schmittling RJ, Archer GE, Congdon KL, Nair SK, et al. A pilot study of IL-2Rα blockade during lymphopenia depletes
regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma. PLoS One 2012;7:e31046.
86. Zeng J, See AP, Phallen J, Jackson CM, Belcaid Z, et al. Anti-PD-1 blockade and stereotatic radiation produce long-term survival in
mice with intracranial gliomas. Int J Radiat Oncol Biol Phys 2013;86:343-9.
87. Zhang L, Alizadeh D, Van Handel M, Kortylewski M, Yu H, et al. Stat3 inhibition activates tumor macrophages and abrogates glioma
growth in mice. Glia 2009;57:1458-67.
88. Wei J, Wang F, Kong LY, Xu S, Doucette T, et al. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of
glioma. Cancer Res 2013;73:3913-26.
89. Avril T, Vauleon E, Tanguy-Royer S, Mosser J, Quillien V. Mechanisms of immunomodulation in human glioblastoma. Immunotherapy
2011;3:42-4.
90. Waziri A. Glioblastoma-derived mechanisms of systemic immunosuppression. Neurosurg Clin N Am 2010;21:31-42.
91. Albesiano E, Han JE, Lim M. Mechanisms of local immunoresistance in glioma. Neurosurg Clin N Am 2010;21:17-29.
92. Brown CE, Alizadeh D, Starr R, Weng L, Wagner JR, et al. Regression of glioblastoma after chimeric antigen receptor T-cell therapy.
New Eng J Med 2016;375:2561-9.
93. Jindal V. Role of chimeric antigen receptor T cell therapy in glioblastoma multiforme. Mol Neurobiol 2018;55:8236-42.
94. Tan AC, Heimberger AB, Khasraw M. Immune checkpoint inhibitors in gliomas. Curr Oncol Rep 2017;19:23.
95. Nicholas S, Mathios D, Ruzevick J, Jackson C, Yang I, et al. Current trends in glioblastoma multiforme treatment: radiation therapy and
immune checkpoint inhibitors. Brain Tumor Res Treat 2013;1:2-8.
96. Jackson C, Ruzevick J, Brem H, Lim M. Vaccine strategies for glioblastoma: progress and future directions. Immunotherapy
2013;5:155-67.
97. Xu LW, Chow KK, Lim M, Li G. Current vaccine trials in glioblastoma: a review. J Immunol Res 2014;2014:796856.
98. Sampson JH, Mitchell DA. Vaccination strategies for neuro-oncology. Neuro Oncol 2015; doi: 10.1093/neuonc/nov159.
99. Desai R, Suryadevara CM, Batich KA, Farber SH, Sanchez-Perez L, et al. Emerging immunotherapies for glioblastoma. Expert Opin
Emerg Drugs 2016;21:133-45.
100. Huang B, Zhang H, Gu L, Ye B, Jian Z, et al. Advances in immunotherapy for glioblastoma multiforme. J Immunol Res
2017;2017:3597613.